Continue to Site

Roche to donate more medicines and diagnostics to Ukraine

By Brian Buntz | March 23, 2022

Roche With the war in Ukraine on the verge of entering its second month, Roche (SIX:RO, ROG; OTCQX:RHHBY) has announced that it will donate additional medications and diagnostics to the country.

The company had announced its plans to aid the country in early March, which included 150,000 packs of the antibiotic Rocephin, an antibiotic WHO lists as an essential medicine.

Roche will donate an additional 4,600 packs of medicines for influenza, rheumatoid arthritis, spinal muscle atrophy and some cancers. Additionally, the company will provide reagents and consumables to support testing 120,000 blood donations and 31,000 units for diabetes management.

In addition to providing supplies to Ukraine, several pharma countries, including Lilly, GSK and Pfizer, have announced plans to curtail operations or realign their business focus in Russia.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.